Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 1;49(4):178-179.
doi: 10.1097/ICL.0000000000000969. Epub 2022 Dec 30.

In Response

Affiliations

In Response

Magdalena Blaszkowska et al. Eye Contact Lens. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

References

    1. Richdale K, Tomiyama ES, Novack GD, et al. . Compounding of low concentration atropine for myopia control. Eye & Contact Lens 2022;48:489–492. - PubMed
    1. Therapeutic Goods Administration (TGA) Australian Register of Therapeutic Goods (ARTG). EIKANCE 0.01% atropine sulfate monohydrate 100 microgram/1mL eye drops solution packed in single-dose ampoules (331960). Australian product information. (Eikance 0.01% eye drops (atropine sulfate monohydrate) sterile ophthalmic solution). Available at: https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&.... Accessed December 27, 2022.
    1. Lee SS-Y, Lingham G, Sanfilippo PG, et al. . Incidence and progression of myopia in early adulthood. JAMA Ophthalmol 2022;140:162–169. - PMC - PubMed
    1. Lee SS-Y, Lingham G, Blaszkowska M, et al. . Low-concentration atropine eyedrops for myopia control in a multi-racial cohort of Australian children: A randomised clinical trial. Clin Exp Ophthalmol 2022;50:1000–1012. - PMC - PubMed
    1. Yam JC, Jiang Y, Tang SM, et al. . Low-concentration atropine for myopia progression (LAMP) study: A randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025% and 0.01% atropine eye drops in myopia control. Ophthalmology 2019;126:113–124. - PubMed